MY184940A - Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent - Google Patents

Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent

Info

Publication number
MY184940A
MY184940A MYPI2011700079A MYPI2011700079A MY184940A MY 184940 A MY184940 A MY 184940A MY PI2011700079 A MYPI2011700079 A MY PI2011700079A MY PI2011700079 A MYPI2011700079 A MY PI2011700079A MY 184940 A MY184940 A MY 184940A
Authority
MY
Malaysia
Prior art keywords
rhinocerus
lignosus
tiger
inflammatory agent
milk mushroom
Prior art date
Application number
MYPI2011700079A
Inventor
Sook Shien Lee
Si Mui Sim
Nget Hong Tan
Shin Yee Fung
Original Assignee
Univ Malaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaya filed Critical Univ Malaya
Priority to MYPI2011700079A priority Critical patent/MY184940A/en
Publication of MY184940A publication Critical patent/MY184940A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is to provide a novel anti-inflammatory compound which has excellent anti-inflammatory activity with reduced side effects and which can be prepared starting with a medicinal mushroom used in functional food, nutraceutical or pharmaceutical formulation.
MYPI2011700079A 2011-06-01 2011-06-01 Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent MY184940A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2011700079A MY184940A (en) 2011-06-01 2011-06-01 Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2011700079A MY184940A (en) 2011-06-01 2011-06-01 Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent

Publications (1)

Publication Number Publication Date
MY184940A true MY184940A (en) 2021-04-30

Family

ID=80001620

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2011700079A MY184940A (en) 2011-06-01 2011-06-01 Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent

Country Status (1)

Country Link
MY (1) MY184940A (en)

Similar Documents

Publication Publication Date Title
PH12015501421A1 (en) Long-acting formulations of insulin
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
CO6771409A2 (en) Substituted 1-benzylcycloalkylcarboxylic acids and their use
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
IN2014DN06104A (en)
IL231170A (en) Nitrogen mustard derivative compound, a pharmaceutical composition, use of the compound in the preparation of a medicament and the compound for use as medicament
PH12015500900A1 (en) A stabilized pemetrexed formulation
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX366090B (en) Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients.
MX340147B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2014004920A (en) Novel pyrazine derivatives.
CO7160080A2 (en) Lipid compositions of racecadot
WO2012074830A3 (en) Modified release tranexamic acid formulation
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
MX344189B (en) Formulations of mazindol.
UA105944C2 (en) Drug formulation with theobromine and decongestant for treatment of cough
MX2013013079A (en) Compositions comprising antibacterial agent and tazobactam.
NZ717192A (en) Anti-inflammatory tripeptides
MX355719B (en) Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum.
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
WO2013064388A3 (en) Cosmetic formulation containing n-acyl-phytosphingosine
MX2013010947A (en) Gallium complexes, pharmaceutical compositions and methods of use.